CGI Group is a top pick at Goodreid Investment

CGI Group (CGI Group Stock Quote, Chart, News: TSX:GIB.A, NYSE:GIB) has the proven track record to continue on its hot streak, says Brian Madden, vice-president and portfolio manager at Goodreid Investment Council, who names the technology services company a Top Pick for 2018.

One of the few bright spots on the Canadian investment scene this year, CGI Group is up nine per cent in 2018 compared to the TSX which has lost over three per cent of its value.

Madden says there are a number of reasons for its success. “There’s an element of benefit from US tax reform here, as a lot of [CGI’s] business does come out of the US —their largest customer is the US government and the US military,” he said, in conversation with BNN.

“They’re increasingly weaving their own intellectual property into some of their client solutions, so that has long term margin implications for the company,” says Madden. “It’s undemanding in terms of its multiple — 15, 16, 16.5 times earnings. It grew earnings at about a ten per cent clip over the last year, and it’s been doing a series of small acquisitions to infill white space in the portfolio geographically and in terms of technology.”

Going forward, management at CGI has stated that their goal is to double in size over the next five to seven years. Last month, the company announced two new major contracts with SNCF, France’s public railway group, to help manage its human resource IT along with a portfolio of applications for its critical railway network maintenance.

“It remains to be seen whether [CGI] will pull the trigger on a large transformational acquisition, but they certainly have the balance sheet to do that and the wherewithal to integrate that, as they done oftentimes in their history,” says Madden. “They’re great compounders of wealth and have been for a very, very long time.”

Tagged with: gib.a
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

This company’s deal with Anthropic is huge, analyst says

Riot Platforms’ (Riot Platforms Stock Quote, Chart, News, Analysts, Financials NASDAQ:RIOT) new 910-megawatt data centre lease at its Corsicana campus… [Read More]

1 day ago

AIRO Group Holdings is a buy, this analyst says

Roth Capital Partners analyst Craig Irwin initiated coverage of AIRO Group Holdings (Airo Group Holdings Stock Quote, Chart, News, Analysts,… [Read More]

1 day ago

Decisive Dividend Corporation is a buy, this analyst says

Beacon Securities analyst Russell Stanley maintained his “Buy” rating and $12.50 target on Decisive Dividend Corporation (Decisive Dividend Corporation Stock… [Read More]

1 day ago

5N Plus: this analyst just hiked his price target

Ventum Capital Markets analyst Daniel Lavoie raised his target on 5N Plus (5N Plus Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 days ago

What to make of the Organigram, Aurora Cannabis deal?

Organigram Global (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) has agreed to acquire Aurora Cannabis for approximately $561-million… [Read More]

2 days ago

Is Thinkific (TSX:THNC) a buy right now?

Thinkific Labs’ (Thinkific Labs Stock Quote, Chart, News, Analysts, Financials TSX:THNC) third-quarter results suggest recent price increases and growth in… [Read More]

2 days ago